CSIMarket Company Name, Ticker, Customers, else..
 

Endonovo Therapeutics Inc   (ENDV)

Endonovo Therapeutics Inc 's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

ENDV Sales vs. its Competitors Q3 2023


Comparing the current results to its competitors, Endonovo Therapeutics Inc reported Revenue decrease in the 3 quarter 2023 year on year by -86.13 %, faster than the overall decrease of Endonovo Therapeutics Inc 's competitors by -44.3 %, recorded in the same quarter.

• List of ENDV Competitors





Revenue Growth Comparisons




Net Income Comparison

Endonovo Therapeutics Inc , faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<<  ENDV Stock Performance Comparisons





  

Overall company Market Share Q3 2023
Overall company, revenue fell by -86.13 % and company lost market share, to approximately 0.02 %.




<<  More on ENDV Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Endonovo Therapeutics Inc




Arch Therapeutics Inc
Share Performance



-82.30%
One Year
Arch Therapeutics Inc
Profile

Arch Therapeutics Inc's business model focuses on the development and commercialization of novel self-assembling peptide-based technologies for use in the healthcare industry.

More about Arch Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 0.889 mill. $ 0.148 mill. $ -12.263 mill.


Vycor Medical Inc
Share Performance



-27.54%
30 Days
Vycor Medical Inc
Profile

Vycor Medical Inc has a business model focused on developing and commercializing innovative medical devices and technologies in the healthcare industry.

More about Vycor Medical Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1.669 mill. $ 1.807 mill. $ -0.060 mill.


Meridian Bioscience Inc
Share Performance



0.00%
This Year
Meridian Bioscience Inc
Profile

Meridian Bioscience Inc operates as a diagnostic test manufacturer and distributor, primarily focused on gastrointestinal diseases and respiratory infections. Their business model involves producing and selling a wide range of diagnostic testing products to healthcare providers, including hospitals, commercial labs, and reference labs, aiming to provide accurate and reliable results for disease detection and monitoring. Through their global sales force, they also offer a comprehensive customer support network and engage in strategic partnerships to expand their market reach and drive growth.

More about Meridian Bioscience Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 136.517 mill. $ 301.579 mill. $ -2.702 mill.


Therapeutic Solutions International Inc
Share Performance



0.00%
One Year
Therapeutic Solutions International Inc
Profile

Therapeutic Solutions International Inc is a company that operates under a business model focused on researching, developing, and commercializing cutting-edge treatments and therapies for various medical conditions. Their approach involves identifying innovative technologies and products, conducting rigorous scientific research, and partnering with healthcare professionals and organizations to bring their solutions to the market. Through their business model, they aim to improve patient outcomes and revolutionize medical treatments across different fields.

More about Therapeutic Solutions International Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 0.491 mill. $ 0.085 mill. $ -3.692 mill.


Marizyme Inc
Share Performance



+10.48%
One Year
Marizyme Inc
Profile

Marizyme Inc operates on a business model that focuses on developing and commercializing innovative therapies derived from marine sources. The company utilizes enzymatic technologies to create effective and sustainable solutions for various medical applications and is committed to improving patient outcomes by advancing the development of novel therapeutics. Marizyme aims to establish partnerships and collaborations with healthcare organizations and pharmaceutical companies to bring its products to market efficiently and effectively.

More about Marizyme Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 4,909.319 mill. $ - mill. $ -26.217 mill.

5 more competitors available

Sign in to see all competitors

Sign In Create Free Account

Sources: Endonovo Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Endonovo Therapeutics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.